Skip to Content

Seven Must-Read Stories (Week ending January 16, 2016)

Another chance to catch the most interesting and important articles from the previous week on MIT Technology Review.
  1. Illumina’s Bid to Beat Cancer with DNA Tests
    The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
  2. Hope in a Glove for Parkinson’s Patients
    A wearable device promises to help steady hand tremors by using an old technology—gyroscopes.
  3. Parents Turn to Prozac to Treat Down Syndrome
    The disorder known as trisomy 21 is untreatable. Or is it? Some families think an antidepressant could help.
  4. Big Pharma Doubles Down on CRISPR for New Drugs
    A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
  5. RIP David Bowie, Internet Pioneer
    Long before MySpace, the late rock star was focused on connecting with his fans online.
  6. In Pursuit of an Affordable Tablet for the Blind
    By borrowing from microfluidics, a team of University of Michigan researchers are reinventing the Braille display to be cheaper and more useful.
  7. Advanced Nuclear Startup Terrestrial Energy Lands Initial Funding
    Canadian startup pursuing an advanced molten-salt nuclear reactor gets significant outside backing.
  8. <

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.